Introduction {#Sec1}
============

Neutropenic oncologic immunocompromised patients have a significant risk of serious infections when diagnosed with an absolute neutrophil count (ANC) \< 1.0 cells × 10^9^ and especially when the ANC decreases to \< 0.1 cells × 10^9^/L \[[@CR1]--[@CR4]\]. On the other hand, acute transient neutropenia (defined as an absolute neutrophil count, ANC, \< 1.5 cells × 10^9^/L) in immunocompetent patients is mainly a benign and transient condition related to an intercurrent viral infection, particularly in afebrile patients \[[@CR5]--[@CR8]\]. In immunocompetent febrile patients, while a viral etiology is still common, serious bacterial infections (SBI) should always be taken into consideration \[[@CR8], [@CR9]\].

In the nine studies (two prospective) published in the pediatric medical literature during 2010--2020 and dealing with the topic of acute neutropenia diagnosed in immunocompetent children, 7 enrolled only febrile patients while the other 2 enrolled both non-febrile and febrile neutropenic patients \[[@CR10]--[@CR18]\]. The number of patients described varied from study to study (range 32--1888) and the majority of patients were younger than 2 years of age (range 47--86.4%). The percentages of patients with severe neutropenia (ANC \< 0.5 cells × 10^9^/L) ranged from 8.5 to 100% (two studies \[[@CR10], [@CR16]\] enrolled only patients with severe neutropenia) \[[@CR16]--[@CR18]\]. The rates of SBIs among the enrolled patients were reported in six studies and ranged from 1.9 to 23.6% \[[@CR10], [@CR12], [@CR14]--[@CR17]\]. No SBIs were reported in two studies \[[@CR10], [@CR11]\]. Infectious diseases were associated with acute neutropenia in 12.1--63.8% patients \[[@CR13], [@CR14], [@CR16], [@CR18]\]. Bacterial infections associated with neutropenia were reported in 5.3--21.9% patients \[[@CR10], [@CR14], [@CR16], [@CR18]\]. Viral investigations were completed in five studies \[[@CR12]--[@CR14], [@CR16], [@CR18]\] and the isolation ranges were between 5.1 and 55% of the enrolled patients. In the two studies where a detailed definitive viral diagnosis was reported, human herpes virus 6, enteroviruses, and influenza A virus \[[@CR12]\] and RSV; influenza A; and parainfluenza 1 viruses \[[@CR18]\] were the most commonly isolated pathogens. In one of the two studies completed in Greece, neutropenia following a Coxackie, mumps, EBV, or RSV infection lasted for more than 1 month \[[@CR13]\]. Malignancies associated with acute neutropenia were diagnosed in two studies \[[@CR14], [@CR18]\] at rates of 0.8--2.6% and included acute lymphoblastic leukemia and myelodysplasia. The mean time for recovery of the ANC in evaluable patients ranged from 6 to 16.7 days \[[@CR12], [@CR16]\].

The published studies reporting on acute neutropenia in immunocompetent infants and children were characterized by lack by heterogeneity in terms of patient enrollment criteria, investigations performed and appropriate follow-up. The information on the risk of SBIs in the patients with severe neutropenia is also limited, the management of these patients is controversial and there is agreement that a more prudent approach is warranted in these patients \[[@CR19]\]. Furthermore, none of the presented studies made a direct comparison between febrile and non-febrile neutropenic immunocompetent patients in respect to severity of the condition, its various etiologies, management, and outcome. Therefore, the main purpose of the present study was to describe and compare the epidemiologic, etiologic, microbiologic, clinical, and outcome characteristics of febrile and non-febrile immunocompetent children hospitalized with acute neutropenia at the Soroka University Medical Center (SUMC), Beer-Sheva, Israel, during 2013--2015.

Patients and methods {#Sec2}
====================

This retrospective study was conducted at the pediatric departments of the SUMC during a 3-year period (1.1.2013--31.12.2015). The pediatric division of the hospital received approximately 40,000 visits per year during the study period. Children presenting with new neutropenia and hospitalized because of this condition constituted the study cohort. Patients with previous history of neutropenia (like chronic, cyclic or autoimmune neutropenia, or aplastic anemia) ) and with any primary diagnoses known to cause neutropenia like malignancy (leukemia, lymphoma, solid tumors, brain tumors), immunosuppressive disorders (primary immunodeficiencies, cystic fibrosis, systemic erythematous lupus, rheumatoid arthritis, or chronic steroid therapy), and therapies or medications causing neutropenia were excluded from the study.

The study was conducted after obtaining approval from the ethics committee of SUMC.

Patients were evaluated in the Emergency Department, during hospitalization (where additional WBC counts were performed) and at the outpatient pediatric clinics (at least once during a one-month follow-up after discharge, when WBC measurements were repeated). All patients had the medical record reviewed for demographic and history data, clinical and laboratory findings (presence/absence of fever, risk factors for SBI, total WBC count, ANC and the results of urine, blood, and/or cerebrospinal fluid culture, serology and virology tests), disease management, and follow-up.

Neutropenia {#Sec3}
-----------

Neutropenia was defined as an ANC \< 1.5 × 10^9^/L. According to severity, neutropenia was defined as severe (ANC \< 0.5 × 10^9^/L), moderate (ANC between 0.5 and 1.0 × 10^9^/L), or mild (ANC between 1.0 and 1.5 × 10^9^/L). Leukopenia was defined as a total WBC count of \< 5.0 × 10^9^/L. Thrombocytopenia was defined as a platelet count of \< 150.0 × 10^9^/L. Anemia was defined as hemoglobin value greater than two standard deviations below the mean for reference population.

Serious bacterial infections {#Sec4}
----------------------------

The following infections were considered SBIs for the purpose of the study: bacteremia, bacterial meningitis, pneumonia, urinary tract infection, bacterial gastroenteritis, osteomyelitis and septic arthritis \[[@CR8], [@CR9], [@CR20], [@CR21]\]. Diagnosis of UTI was made on the basis of (1) the presence of at least 50,000 colonies/ml of one uropathogenic organism in a specimen of urine obtained by bladder catheterization or suprapubic aspiration in patients \< 2 years of age and urine midstream for older patients and (2) a positive urinalysis by dipstick.

All cases of pneumonia included were alveolar as this was considered suggestive of a bacterial etiology. Brucellosis and rickettsiosis were also considered SBIs.

Microbiology {#Sec5}
------------

Blood cultures were performed using the Bactec Becton Dickinson (Benex Limited, Shannon, County Clare, Ireland) system; the Vitel Bio Merieux (Boston, MA) system was used for bacterial identification. Cerebrospinal fluid was examined by culture for conventional bacterial pathogens and by polymerase chain reaction (PCR) (when recommended) for herpes simplex viruses 1 and 2 and enteroviruses. Serum samples were tested for VCA-IgM and EBNA-IgG antibodies for Epstein-Barr virus and cytomegalovirus. Skin lesions were examined for herpes simplex virus by PCR.

All the respiratory viruses were tested simultaneously with a multiplex real-time polymerase chain reaction (mqRT-PCR) able to identify 12 respiratory viruses \[[@CR22]\]. Each sample was tested in parallel, in three test tubes, for the following viruses: influenza A and B, parainfluenza 2 and 3, human respiratory syncytial virus (RSV), human metapneumovirus (hMPV), rhinovirus, adenovirus, and coronaviruses 229E, HKU1, OC43, and NL63. Amplification was carried using the RNA UltraSense One-Step qRT-PCR System (Invitrogen, Carlsbad, CA, USA). The sensitivity rate was identical at 100% for all virus groups except coronaviruses, in which the sensitivity of the pooled samples was 89.3%.

Diagnosis of brucellosis was established according to a clinical presentation compatible with the disease, a positive blood culture, and/or a standard tube agglutination test titer \> 1/160 obtained at admission in all patients \[[@CR23], [@CR24]\]. Diagnosis of rickettsiosis was established by determining the presence of IgG and IgM antibodies to murine typhus and spotted fever group rickettsia, by using a micro immunofluorescence assay \[[@CR25]\].

Management {#Sec6}
----------

The indications for hospitalization included (1) neutropenia \< 500 WBC × 10^9^/L; 2) the clinical status of the neutropenic patient; (3) the infectious focus diagnosed and the need for initiation of intravenous antibiotic treatment (like pneumonia, urinary tract, dysentery); and (4) diagnosis or suspicion of brucellosis and rickettsiosis, need for initiation of empiric or definitive antibiotic treatment for these two diseases and need for patient monitoring during hospitalization.

During the study period, the management of patients with neutropenia was dictated by patients' condition and neutropenia severity. Ill-appearing patients, regardless of neutropenia severity, and those with severe neutropenia \< 0.5 cells × 10^9^/L were considered at risk of SBI, were hospitalized, and then started on empiric broad-spectrum antibiotics after obtaining at least 1 blood culture.

Every hospitalized patient was followed, after admission, with at least one WBC count during hospitalization or during the one-month follow-up period after discharge.

Data analysis {#Sec7}
-------------

Data analysis was conducted using the SPSS 22.0 package. Analysis of variance and *t* tests were used to compare continuous variables. The χ2 or Fisher exact tests were used for comparison of categorical variables. Kaplan--Meier survival curves were built for the three neutropenia severity groups, and these groups were compared with the use of the log-rank test. *P* values \< 0.05 were considered significant.

Results {#Sec8}
=======

Overall, 664 previously healthy, presumed immunocompetent infants and children \< 18 years of age (the study population) were diagnosed with acute neutropenia and hospitalized at the pediatric departments of SUMC. Of them, 411 (61.9%) had a body temperature \> 38.0 °C and 253 (38.1%) were non-febrile at admission. There were 220 (33.1%) Jewish patients and 434 (65.4%) Bedouin patients (data on ethnicity was missing in 10, 1.5% patients). There were 370 (55.7%) male and 294 (44.3%) female patients. There were 425 (64.0%), 125 (18.8%), 48 (7.2%), and 66 (9.9%) patients aged 0--2, 3--6, 7--12, and \> 12 years, respectively. No differences were recorded in the distribution of febrile vs. non-febrile patients among these 4 age groups, respectively (*P* = 0.691). None of the enrolled patients suffered from previously diagnosed immunocompromising diseases, malignancies, or hematologic conditions associated with neutropenia.

The most common clinical conditions/symptoms associated with neutropenia at admission included (according to the involved body system) the respiratory, urinary, skin, nervous, and otolaryngology systems and were diagnosed as bronchiolitis, vomiting, urinary tract infection, rash, afebrile convulsions, and tonsillitis (31, 25, 21, 18, 10, and 10 cases, respectively). More cases of upper respiratory tract infections were diagnosed in the group of patients with fever \> 38.0 °C compared with afebrile patients (6.1% vs. 1.6%). No other significant differences in the distribution of the conditions/symptoms associated with neutropenia at admission were recorded when comparing the febrile and the non-febrile patient groups.

Of the 664 enrolled patients, 24 (3.6%), 71 (10.7%), 213 (32.1%), and 356 (53.6%) had neutrophil counts \< 200, 200--500, 501--1000, and 1001--1500 cells × 10^9^/L, respectively. Overall, 95 (14.3%) patients suffered from severe neutropenia (\< 500 × 10^9^/L). The distribution of patients among the four neutropenia groups was not different between the febrile and the non-febrile groups of patients (*P* = 0.175). There were 42.4%, 24.8%, and 21.0% patients with leukopenia, anemia, and thrombocytopenia, respectively. While no differences were recorded between the febrile and non-febrile patient groups with respect to the distribution of leukopenia and thrombocytopenia cases, more patients suffering from anemia were recorded in the non-febrile vs. the febrile group (29.8% *vs*. 21.8%, *P* = 0.03).

Among the 411 neutropenic febrile patients, no differences were recorded in the patient distribution within the four neutropenia severity groups between the patients with a fever between 38.0--39.0 °C and the patients with fever \> 39.0 °C (*P* = 0.127) and no differences were recorded between these two febrile patients groups in respect to the distribution of leukopenia, anemia, and thrombocytopenia.

Etiology {#Sec9}
--------

### Bacterial infections (Table [1](#Tab1){ref-type="table"}) {#Sec10}

Positive blood cultures were recorded in 12/633 (1.9%) evaluable patients. The most frequently isolated organisms were *Staphylococcus aureus*, *Enterobacter*, and *Brucella* (four, two, and two patients, respectively). Brucellosis was diagnosed in 20 patients (two positive blood cultures, 19 positive serologies, 1 patient with both positive blood culture and positive serology, one patient with positive blood cultures and negative serology). No differences were recorded in the distribution of brucellosis cases among febrile vs. non-febrile patients. Rickettsiosis was found in 14 (20.6% of the evaluated patients), with no differences between febrile and non-febrile patients. Overall, *Brucella* and rickettsial infections were diagnosed in 34 (5.1%) patients. No cases of meningitis were recorded. Sixteen cases of alveolar pneumonia were diagnosed, 12 in febrile patients, and four in non-febrile patients (*P* = 0.405). Urine cultures were performed in 205 (30.9%) neutropenic patients and returned positive in 34 (16.6%); *Escherichia coli* and *Klebsiella* spp. were the most commonly isolated uropathogens, with no differences in distribution between febrile and non-febrile patients.Table 1Bacterial etiologies: 664 patients\* (febrile vs*.* non-febrile) with newly diagnosed neutropeniaTotal *n* = 664Febrile (total) *n* = 411Not febrile *n* = 253*P* value febrile vs*.* not febrileBlood cultures (bacterial)633 (95.3)390 (94.9)243 (96.0)0.342Positive12 (1.9)8 (2.1)4 (1.6)1.000*Staphylococcus aureus*4 (0.6)3/390 (0.8)1/243 (0.4)1.000*Enterobacter*2 (0.3)1/390 (0.3)1/243 (0.4)1.000*Brucella*2 (0.3)2/390 (0.5)00.526*Salmonella* spp.1 (0.2)1/390 (0.3)01.000*Escherichia coli*1 (0.2)01/243 (0.4)0.384*Acinetobacter* spp.1 (0.2)01/243 (0.4)0.384Blood cultures (fungal)*Candida* spp.1 (0.2)1/390 (0.3)01.000Brucellosis positive serology only (IgM/IgG)-40 tests19\*\*/40 (47.5)15/40 (37.5)15/411 (3.6)4/40 (10.0)4/253 (1.6)1.000Total brucellosis2016/411 (3.9)4/253 (1.6)0.121Rickettsia (IgM)-68 tests14/68 (20.6)11/51 (21.6)3/17 (17.6)1.000Urine cultures205 (30.9)135/411 (32.8)70/253 (27.7)0.161Positive34/205 (16.6)20/135 (14.8)14/70 (20.0)0.454*Escherichia coli*22/205 (10.7)13/135 (9.6)9/70 ( 13.0)0.613*Klebsiella* spp.5/205 (2.4)3/135 (2.2)2/70 (2.9)0.780Other7/205 (3.4)4/135 (3.0)3/70 (4.3)0.621Positive CSF cultures (58 lumbar punctures)000--Stool cultures29 (4.4)209Positive3/29 (10.3)3/20 (15.0)00.532*Campylobacter* spp.2/29 (6.9)2/20 (10.0)01.000*Shigella sonnei*1/29 (3.4)1/20 (5.0)01.000Pneumonia (alveolar)16 (2.4)12/411 (2.9)4/253 (1.6)0.405Septic arthritis due to *Staphylococcus aureus*11/411 (0.2)00.448Ear cultures106/411 (1.5)4/253 (1.6)0.901Positive2/10 (20)2/6 (33.3)0/40.467*Haemophilus influenzae* nontypeable2/10 (20)2/6 (33.3)0/40.467Pharyngeal cultures36 (5.4)23/411 (5.6)13/253 (5.1)0.800Positive8/36 (22.2)6/411(1.5)2/253 (0.8)0.443Group A *Streptococcus*6/36 (16.7)4/411 (1.0)2/253 (0.8)0.809*Kingella kingae*2/36 (5.6)2/411 (0.5)00.266Impetigo2 (0.3)02/253 (0.8)0.07Total patients with bacterial infections96/664 (14.5)67/411 (16.3)29/253 (11.5)0.085Total bacterial infections diagnoses110/664 (16.6)77/411 (18.7)33/253 (13.0)0.091Total serious bacterial infections diagnoses\*\*\*98/664 (14.8)69/411 (16.8)29/253 (11.5)0.060\*Data missing in some patients\*\*1 patient had both blood culture and serology positive, 1 had only positive blood culture, 1 had only positive serology for Brucella spp.\*\*\*7 patients had 2 diagnoses of infectious disease^\$^Including blood, CSF, urine, and stool cultures + positive Brucella serology + positive Rickettsia serology + alveolar pneumonia

Overall, bacterial infections were recorded in 96 (14.5%) neutropenic patients with a trend to higher percentages in febrile patients compared with non-febrile patients (16.3% vs. 11.5%, *P* = 0.085). Serious bacterial infections were diagnosed in 98 (14.8%) neutropenic patients, with higher rates among febrile patients compared with non-febrile patients (16.8% vs. 11.5%, *P* = 0.06).

Of the 96 patients diagnosed with bacterial infection, seven had two simultaneous infections (six with urinary tract infections, three with bacteremia, three with rickettsiosis, one with brucellosis and one with acute gastroenteritis). Overall, 110 diagnoses of infectious diseases were made.

### Bacterial infections: comparison between patients with low fever (38.0--39.0 °C) and patients with high fever (\> 39.0 °C) {#Sec11}

Among the 411 febrile neutropenic patients, 260 (63.3%) and 151 (36.7%) had fever between 38.0--39.0 °C and fever \> 39.0 °C, respectively. No differences were recorded between the two febrile patient groups in respect to the distribution of positive blood cultures and of specific bacterial pathogens isolated in each group, as well as the distribution of alveolar pneumonia and culture-positive urinary tract infections, gastroenteritis, septic arthritis, acute otitis media, and pharyngitis cases. No differences were found between these two groups of febrile patients in respect to the total number of patients with bacterial infections (45/260, 17.3% vs. 22/151, 14.6%, *P* = 0.469), the total number of diagnoses of bacterial infections (45/260, 17.3% vs. 32/151, 21.2%, *P* = 0.331), and the total number of diagnoses of severe infectious diseases (38/260, 14.6% vs. 31/151, 20.5%, *P* = 0.122).

### Viral infections: comparison between febrile and afebrile patients (Table [2](#Tab2){ref-type="table"}) {#Sec12}

Overall, 499 nasal washings were performed and investigated by PCR for eight respiratory viruses. In addition, 82 and 83 serological tests were performed for the diagnosis of EBV and CMV, respectively; 12 PCR examinations each were performed for herpes simplex virus 1 and herpes simplex virus 2. Two hundred and fifty-nine (51.9%) nasal washings returned positive for respiratory viruses, with adenovirus, parainfluenza 3, RSV, and influenza A the most common (15.2%, 13.8%, 8.8%, and 8.8%, respectively). The percentages of patients with adenovirus detection were higher in febrile patients compared with non-febrile patients (*P* = 0.05). No differences were found in the distribution of the other viral pathogens between the febrile and non-febrile neutropenic patients. A total of 688 virologic examinations were performed; of them, 295 (42.9%) returned positive. Twenty-two patients were diagnosed with a mixed bacterial and viral infection.Table 2Viral etiologies: comparison between febrile and non-febrile patientsEtiologyTotal examinations performedPositive (total) *n* (%)Positive febrile *n* (%)Positive non-febrile *n* (%)*P* valueNasal washes499259 (51.9)173/322\* (53.7)86/177\*\*(48.6)0.246RSV49944 (8.8)23/322 (7.1)21/177 (11.9)0.106Adenovirus49976 (15.2)57/322 (17.7)19/177 ( 10.7)0.05Influenza A49944 (8.8)26/322 (8.1)18/177 (10.2)0.532Influenza B49919 (3.8)15/322 (4.7)4/177 (2.3)0.274Parainfluenza 149925 (5.0)16/322 (5.0)9/177 ( 5.1)1.000Parainfluenza 249914 (2.8)11/322 (3.4)3/177 (1.7)0.397Parainfluenza 349919 (13.8)13/322 (4.0)6/177 (3.4)0.907Metapneumovirus49918 (3.6)12/322 ( 3.7)6/177 ( 3.4)1.000EBV8217 (20.7)13/57 (22.8)4/25 (16.0)0.685CMV8318 (21.7)12/56 (21.4)6/27 (22.2)1.000Herpes simplex 1121 (8.3)1/7 (14.3)0/51.000Herpes simplex 212000\*Total nasal washings in febrile patients\*\*Total nasal washings in afebrile patients

When comparing patients \< 2 years of age with older patients, more nasal washings were tested in younger patients (*P* = 0.01). RSV was identified in higher percentages in the group of patients \< 2 years of age (12.3% of all patients examined in this age group compared with 3.6% in patients \> 2 years of age, *P* = 0.001). No differences were recorded in the percentages of other viral pathogens between patients \< 2 years of age compared with older patients.

### Distribution of infectious etiologies in relation to age sub-groups (Table [3](#Tab3){ref-type="table"}) {#Sec13}

In the group of patients aged 61 months--12 years, more non-febrile patients were diagnosed with bacterial infections compared with febrile patients (*P* = 0.049). Among the patients aged 0--24 months, more febrile patients were diagnosed with viral infections compared with afebrile patients (*P* = 0.025).Table 3Infectious etiology according to age groups\*EtiologyTotal positive^\$^*n* (%)Febrile^\#^*n* (%)Non febrile^\#^*n* (%)*P* valueBacterial only\*\*0--24 m (*n* = 425)38/413 (9.2)26/264 (9.8)12/161(7.5)0.40125--60 m (*n* = 125)8/119 (6.7)7/80 (8.8)1/45 (2.2)0.15261 m--12 years (*n* = 48)6/46 (13.0)1/26 (3.8)5/22 (22.7)0.049\> 12 years (*n* = 66)3/61 (4.9)2/41 (4.9)1/25 (4.0)0.868Viral only\*\*\*0--24 m (*n* = 425)133/296 (44.9)93/264 (35.2)40/161 (24.8)0.02525--60 m (*n* = 125)66/98 (67.3)42/80 (52.5)24/45 (53.3)0.92961 m--12 years (*n* = 48)17/34 (50)8/34 (23.5)9/22 (40.9)0.167\> 12 years (*n* = 66)11/46 (23.9)8/46 (17.4)3/25 (12.0)0.549Mixed infection (bacterial and viral pathogen together)0--24 m (*n* = 425)18/286 (6.3)13/264 (4.9)5/161 (3.1)0.36625--60 m (*n* = 125)3/92 (3.3)3/80 (3.8)0/45 (0)0.18961 m--12 years (*n* = 48)1/32 (3.1)1/34 (2.9)0/22 (0)0.417\> 12 years (*n* = 66)0/42 (0)0/46 (0)0/25 (0)--\*Data missing for some patients (blood cultures and viral testing not performed in all patients); serology performed in accordance with clinical indications\*\*Bacterial only group include: positive blood, urine, CSF, joint, stool, pharyngeal, and/or ear culture + diagnosis of pneumonia (alveolar) + positive Brucella serology + positive Rickettsia serology\*\*\*Viral only: positive nasal wash, positive EBV and CMV serology, and/or PCR and positive HSV-PCR\*\*\*^\$^The denominator represents the number of patients tested for the respective etiology among the respective age group\#The denominator represents the number of febrile or non-febrile patients in each age group

### Relationship between temperature and severity of neutropenia in various etiologic groups (Table [4](#Tab4){ref-type="table"}) {#Sec14}

No differences were recorded in the total number of patients diagnosed with infectious conditions between severely neutropenic patients and patients with mild and moderate neutropenia (\> 500 × 10^9^/L)--(*P* = 0.557). In patients with an infectious etiology, no differences were found between severely neutropenic patients and patients with mild and moderate neutropenia in the percentages of febrile and non-febrile patients (*P* = 0.488). No differences were also found when comparing the distribution of the various infectious etiologies (bacterial, viral, and mixed) between severely neutropenic patients and patients with mild and moderate neutropenia and also between febrile and non-febrile patients.Table 4Relationship between temperature and severity of neutropenia in various etiologic groups (data not available for all patients)EtiologyANC\* \< 500 (× 10^9^/L) *N*=ANC \> 500 (× 10^9^/L) *N*=*P* valueBacterial only\*\*8/92 (8.7)69/551 (12.5)0.383Febrile7/8 (87.5)47/69 (68.1)Non-febrile1/8 (12.5)22/47 (31.9)0.423Viral only\*\*\*37/68 (54.4)189/406 (46.6)0.285Febrile26/37 (70.3)125/189 (66.1)Non-febrile11/37 (29.7)64/189 (33.9)0.766Mixed infection (bacterial and viral agent together)3/67 (4.5)20/389 (5.1)1.000Febrile2/3 (66.7015/20 (75.0)Non-febrile1/3 (33.3)5/20 (25)1.000Infectious etiology49/93 (52.7)278/568 (48.9)0.557Febrile36/49 (73.5)187/278 (67.3)Non-febrile13/49 (26.5)91/278 (32.7)0.488*ANC*, absolute neutrophil count\*\*Bacterial only group include: positive blood culture, urine culture, CSF culture, joint culture, stool culture, pharyngeal culture, and ear culture + diagnosis of pneumonia (alveolar) + positive Brucella serology + positive Rickettsia serology\*\*\*Viral only: positive nasal wash, positive EBV and CMV serology and positive HSV PCR

### Malignancies {#Sec15}

Six (0.9%) of the 664 enrolled patients were diagnosed during hospitalization with malignancy (acute leukemia in all six). Of them, three were \< 15 months of age, three were of Jewish ethnicity/three were of Bedouin ethnicity and three had a fever \> 38.0 °C at admission. The ANC in five of them was between 1.06 and 1.34 × 10^9^/L and was 0.56 × 10^9^/L in the sixth patient. Anemia was recorded in one patient and thrombocytopenia in one additional patient. An infectious etiology was determined in four patients (one with RSV bronchiolitis, one with acute otitis media caused by *H. influenzae* non-typeable, one with mixed adenovirus and CMV infection and one with brucellosis and influenza A + B infection).

### Follow-up (Table [5](#Tab5){ref-type="table"}) {#Sec16}

A follow-up WBC count was retrieved in 323 (48.6%) patients during the time period of 1 month after the initial WBC count. Neutropenia resolved in 163/323 (50.5%). In patients with viral etiology, the number of patients with resolution of neutropenia was lower than the number of patients without resolution of neutropenia (42.5% vs. 72.1%, *P* \< 0.001). No differences were recorded between patients with resolution of neutropenia compared with patients without resolution of neutropenia among children with bacterial and mixed etiologies. No differences were recorded in the percentages of patients with resolution of neutropenia compared with patients without resolution of neutropenia among all four severity groups. No differences were recorded in the rates of neutropenia resolution between febrile and non-febrile children among all four severity groups.Table 5A one-month follow-up on neutropenia by age, etiology and severity of neutropeniaNumber of patients investigated (%)Neutropenia Resolved (%)Neutropenia not resolved (%)*P* valuePatients with follow-up CBC323/664 (48.6)163 (50.5)160 (49.5)Febrile207/323 (64.5)100/163 (61.3)107/160 (66.9)Non-febrile116/323 (35.9)63 (38.7)53 (33.1)0.358EtiologyBacterial only\*38/314 (12.1)22/159 (13.8)16/155 (10.3)0.435Febrile28/38 (73.7)15/22 (68.2)13/16 (81.3)Non-febrile10/38 (26.3)7/22 (31.8)3/16 (18.8)0.469Viral only\*\*256/323 (79.3)54/127 (42.5)93/129 (72.1)\< 0.001Febrile100/256 (39.1)37/54 (68.5)63/93 (67.70Non-febrile47/256 (18.4)17/54 (31.5)30/93 (32.3)1.000Mixed infection19/247 (7.7)10/123 (8.1)9/124 (7.3)0.985Febrile14/19 (73.7)7/10 (70)7/9 (77.8)Non-febrile5/19 (26.3)3/10 (30)2/9 (22.2)1.000Severity of neutropeniaANC\*\*\* ≤ 200 cells × 10^9^/L15/323 (4.7)7/163 (4.3)8/160 (5.0)0.763Febrile13/15 (86.7)6/7 (85.7)7/8 (87.5)Non-febrile2/15 (13.3)1/7 (14.3)1/8 (12.5)1.000ANC = 201--500 cells × 10^9^/L36/323 (11.1)17/163 (10.4)19/160 (11.9)0.680Febrile24/36 (66.7)14/17 (82.4)10/19 (52.6)Non-febrile12/36 (33.3)3/17 (17.6)9/19 (47.4)0.125ANC = 501--1000 cells × 10^9^/L107/323 (33.1)55/163 (33.7)52/160 (32.5)0.813Febrile66/107 (61.7)31/55 (56.4)35/52 (67.3)Non-febrile41/107 (38.3)24/55 (43.6)17/52 (32.7)0.335ANC \> 1000 cells × 10^9^/L165/323 (51.1)84/163 (51.5)81/160 (50.6)0.870Febrile104/165 (63.0)49/84 (58.3)55/81 (67.9)Non-febrile61/165 (37.0)35/84 (41.7)26//81 (32.1)0.266\*Bacterial only group include: positive blood culture (not including brucellosis), urine culture, CSF culture, joint culture, stool culture, pharyngeal culture, and ear culture + diagnosis of pneumonia\*\*Viral only: positive nasal wash, positive EBV and CMV serology, and positive HSV PCR\*\*\*ANC = absolute neutrophil count

Table [6](#Tab6){ref-type="table"} presents a multi-variate analysis by Cox regression predicting the resolution of neutropenia as a function of fever at the time of diagnosis, patient age (0--2 years and \> 2 years of age), and severity of neutropenia. No significant differences were recorded in the rates of resolution of neutropenia as a function of these three parameters.Table 6Correction of neutropenia during a 1-month follow-up period, as function of maximum temperature at admission, degrees of temperature (fever between 38--39 °C and \> 39 °C) and severity of neutropenia: multivariate analysis by Cox regressionVariables in the equationBSEWalddfSig.Exp(B)95.0% CI for Exp(B)LowerUpperMaximum temperature (at home and at admission) (2 Sub-Groups)− 0.2230.1611.91610.1660.8000.5831.097Neut_ABS ≤ 500 cells\\mm30.1180.2210.28510.5931.1260.7291.737Age Group 2 subgroups (at hospitalization)− 0.2540.1672.29510.1300.7760.5591.077

Figure [1](#Fig1){ref-type="fig"} compares the resolution of neutropenia between febrile and non-febrile patients; no differences were found in the resolution of neutropenia between the two groups (*P* = 0.166).Fig. 1Comparison between the resolution of neutropenia in febrile *vs*. non-febrile patients

Figure [2](#Fig2){ref-type="fig"} compares the resolution of neutropenia between patients with fever of 38.0--39.0 °C and those with fever \> 39.0 °C; no differences were found in the resolution of neutropenia between the two groups (*P* = 0.244).Fig. 2Comparison between resolution of neutropenia in patients with fever of 38.0 -- 39.0°C and those with fever \> 39.0°C

Figure [3](#Fig3){ref-type="fig"} compares the resolution of neutropenia between the 3 different severity degree groups (\< 500, 500--1000, and \> 1000 cells × 10^9^/L); no differences were found in the resolution of neutropenia between the three groups (*P* = 0.509).Fig. 3Comparison between resolution of neutropenia among the 3 different severity groups (\<500, 500-1000 and \> 1000 cells × 10^9^/L)

Discussion {#Sec17}
==========

In a recent study published by our group in 2018, David et al. \[[@CR18]\], reported on 601 non-immunocompromised infants and children aged \< 18 years hospitalized during 2010--2012 with acute neutropenia and found that \> 50% of the patients were \< 2 months of age and 27.6% were febrile at admission. The WBC count showed severe neutropenia in 8% of patients, moderate neutropenia in 27.5%, and mild neutropenia in 64.6% of patients. SBIs were diagnosed in 17.9% of patients. *Brucella* and *Rickettsia* spp. were diagnosed in 15.4% and 23.1% of patients evaluated for these conditions. Virologic studies from nasopharyngeal washings were performed in 69 (11.4%) patients with identification of RSV in 51.5% of all positive samples. Overall, an infectious condition (diagnosed by culture, antigen diagnosis, serology, chest x-ray, PCR, and clinical picture) was found in 30.9% patients. Six (1%) patients were diagnosed with acute leukemia. The median length of hospitalization was 2.3 days (10.3 days in patients with neutropenia \< 200 × 10^9^/L). No differences were recorded in the various infectious etiologies between patients with severe neutropenia compared with those with mild or moderate neutropenia. A direct association was found between length of neutropenia, infectious etiology, and severity of neutropenia.

The purpose of the present study was to describe the epidemiological, etiological, clinical, laboratory, and outcome characteristics in a large number of non-immunocompromised patients hospitalized with acute neutropenia. In this study, we paid special emphasis to a comparison between patients with non-febrile versus those with febrile neutropenia, an important topic not analyzed previously in the pediatric medical literature.

Specifically, we looked after the infectious and non-infectious etiology of acute neutropenia diagnosed in the pediatric emergency room, patient distribution according to age, severity of neutropenia and its resolution, and analyzed these parameters as a function of presence or absence of fever at admission. While in the previous study \[[@CR18]\] the number of patients investigated for a viral etiology of the condition was small, we performed in the present study extensive investigations for the detection of various viral infections, leading to more definitive viral diagnoses associated with acute neutropenia. Furthermore, we followed the study patients for a one-month period after their discharge and analyzed the resolution of neutropenia as a function to its severity and association/lack of association with fever at admission.

We found that the number of patients with acute neutropenia and \< 2 years of age was high (64%) and the number of cases with severe neutropenia was low (14.3%). Infectious diseases in general and also bacterial infectious disease (14.5%) and SBIs (14.8%) were recorded in a considerable number of patients, with a trend for higher percentages of the last two conditions in febrile patients compared with non-febrile patients. In addition, a considerable number of cases of acute neutropenia in this study were associated with brucellosis and rickettsiosis. A definitive viral diagnosis was made in a considerable number (42.9%) of the study patients, with higher rates of adenovirus isolations in febrile compared with non-febrile patients and higher rates of RSV isolations in children \< 2 years of age compared with older ages. When comparing patients with severe, moderate, or mild neutropenia; no differences were recorded in the distribution of various infectious etiologies and the number of febrile or non-febrile patients. Malignancies (acute leukemia in all cases) were diagnosed in 0.9% patients with acute neutropenia. Resolution of neutropenia during the one-month follow-up period after hospitalization was achieved in 50.5% of patients, with no differences in the resolution rates as a function of the severity of neutropenia and presence or lack of fever at admission. In patients with viral etiology, the number of patients with resolution of neutropenia was lower than the number of patients without resolution of neutropenia during the follow-up period.

Information on the viral etiology associated with acute neutropenia episodes (febrile or non-febrile at diagnosis) in immunocompetent children is limited. The relevant information about the association between viral etiologies and acute neutropenia derives mainly from the analysis of cases of fever and neutropenia in immunocompromised patients with malignancies. In a study from 2016 \[[@CR26]\] which examined the results of nasal washings in 87 febrile neutropenia episodes in oncological children, real-time PCR for identification of 16 respiratory viruses detected such viruses in 39 (45%) episodes and rhinoviruses were the most frequently isolated ones. A repeated PCR examination established that the viral infection disappeared in 78% of episodes after a mean of 28 days. In another study from 2016 \[[@CR27]\], 1044 febrile episodes were recorded in 525 children suffering from malignancies during a five-year period in three hospitals in Chile. Seventeen respiratory viruses were looked after by PCR performed in nasal washings and at least one respiratory virus was identified in 46% of the neutropenic episodes. The most commonly identified viruses (in decreasing order) were rhinovirus, RSV, parainfluenza, influenza, adenovirus, and human metapneumovirus. The authors reported on a benign course of all episodes of neutropenia where a respiratory virus was identified, as a single pathogen or in the combination of two or more viruses \[[@CR27]\].

We performed a considerable number of viral examinations among the study patients, including PCR for respiratory viruses in nasal washings, serological testing for EBV and CMV, and PCR from skin lesions and blood samples for herpes viruses. More than 50% nasal washings returned positive for respiratory viruses, with adenovirus, parainfluenza 3, RSV, and influenza A, reported as the most common (15.2%, 13.8%, 8.8%, and 8.8%, respectively). The percentages of patients with adenovirus detection were higher in febrile patients compared with non-febrile patients and no differences were found in the distribution of the other viral pathogens between febrile and non-febrile neutropenic patients. Our results suggest that viruses play a major role in the etiology of acute neutropenia not only in immunocompromised, but also in immunocompetent children, and their early detection may be crucial in the management of these cases by withholding empiric antibiotic administration, even in not toxic-looking patients with severe neutropenia.

We found in our study that the rates of bacterial infections (including SBIs) were higher in febrile patients compared with non-febrile ones. These rates are higher than the rates previously reported in the literature and raised the possibility of a more severe disease in neutropenic febrile patients compared with those without fever. These findings require further confirmation in additional studies and add also additional questions with respect to the need for empiric antibiotic treatment in febrile patients. On the other hand, we report in the present study that the severity of neutropenia and also its resolution (during a short one-month follow-up) are not associated with the presence or absence of fever at diagnosis of neutropenia. However, a viral etiology was associated with lower rates of resolution of neutropenia during the follow-up period and we consider that further studies with a longer follow-up of the WBC counts are necessary in order to clarify this issue.

In addition, the higher rates of bacterial infections and SBIs reported in our study may be also related to the high rates of brucellosis and rickettsiosis diagnoses among the study population (representing together 34.7% of the patients with a diagnosis of SBI). These findings confirm previous data that brucellosis is a common disease in southern Israel and additional efforts are needed for its prevention \[[@CR23], [@CR24]\]. In Israel, two types of *Rickettsia* species are described as endemic (*R. typhi* and *R. conorii*) \[[@CR28], [@CR29]\]. The clinical picture of rickettsiosis is not specific, with fever, weakness, muscular pain, and a specific rash in most cases. However, among the Bedouin population living in southern Israel, the disease caused by *R. typhi* does not present with a rash in most cases and is more difficult to diagnose \[[@CR25]\]. Among the patients enrolled in our series of acute neutropenia, we found 14 cases diagnosed with rickettsiosis by serologic examination without any skin manifestations. The hematologic findings in rickettsiosis are not rare; Shalev *et al*. \[[@CR25]\] described in 2006 rates of 68.4%, 18.4%, and 6.6% of anemia, leukopenia, and thrombocytopenia, respectively, among 76 children diagnosed with this disease. According to our findings and similar to the cases of brucellosis previously described, the diagnosis of rickettsiosis should be looked after in children presenting with acute neutropenia, at least in specific geographic areas where these two conditions are common.

The limitations of our study are mainly related to its retrospective nature, which may have contributed to some lacking or missing information on the enrolled patients. In addition, we cannot rule out that some of the patients enrolled in our study might have suffered from ethnical neutropenia (as described in some populations) and not diagnosed previously \[[@CR30]--[@CR32]\]. Regarding the categorization of the enrolled patients as previously immunocompetent, this categorization was of course challenging and it could be argued that in some cases, like in those with neutropenia associated with bacteremia, a previously temporary immunodeficiency status might have occurred in the body innate defenses, permitting, therefore, the access of the pathogens to the bloodstream. Another limitation is related to lack of follow-up data for a considerable number of patients enrolled in the study and, as mentioned, the lack of a longer follow-up period with repeated WBC counts after discharge from hospital.

In conclusion, we found in this study that severe neutropenia was rare and most of the cases occurred in very young patients. SBIs were found in higher percentages among febrile patients compared with non-febrile patients, but we did not find an association between the severity of neutropenia and its resolution during the follow-up period with the presence or absence of fever at the time of diagnosis. Brucellosis and rickettsiosis were frequent SBIs associated with neutropenia in southern Israel.
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